Bioinspired nanomedicines for the management of osteosarcoma: Recent progress and perspectives

Kai Cui1, Fei Ren2, Jian Yu3

  • 1Department of Orthopaedics, The Fourth Affiliated Hospital of China Medical University, No.4 Chongshandong Road, Shenyang, 110032, China.

Materials Today. Bio
|March 28, 2025
PubMed

Insights

Bioinspired nanoparticles offer a promising strategy to overcome the limitations of traditional chemotherapy for osteosarcoma (OS) treatment. These novel agents aim to improve therapeutic outcomes and reduce toxicity in OS management.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Osteosarcoma (OS) is a primary bone cancer common in adolescents and young adults.
  • OS presents treatment challenges due to its aggressive nature, metastasis, and limitations of conventional chemotherapy (poor targeting, toxicity, drug resistance).

Purpose of the Study:

  • To review the biological properties and applications of bioinspired nanoparticles for osteosarcoma management.
  • To highlight advanced bioinspired nanoparticle strategies for improving OS treatment efficacy and safety.

Main Methods:

  • Review of current literature on bioinspired nanoparticles for osteosarcoma.
  • Categorization of nanoparticles based on bioinspired templates (cell membrane, exosomes, proteins, peptides).

Main Results:

  • Bioinspired nanoparticles demonstrate potential for targeted drug delivery and reduced systemic toxicity in OS.
  • Various bioinspired nanoparticle platforms show promise in preclinical models of osteosarcoma.

Conclusions:

  • Bioinspired nanoparticles represent a significant advancement in developing novel therapeutic strategies for osteosarcoma.
  • Further research into these advanced nanomaterials could lead to improved clinical outcomes for OS patients.